| RS387906701 |
NAA10
|
Health Risk |
Pathogenic |
Ogden syndrome, Microphthalmia |
| RS387906702 |
SMC1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Inborn genetic diseases |
| RS387906703 |
RPS6KA3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 19 |
| RS387906704 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS387906705 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS387906706 |
SMPX
|
Health Risk |
Pathogenic |
Hearing loss, X-linked 4 |
| RS387906707 |
SMPX
|
Health Risk |
Pathogenic |
Hearing loss, X-linked 4 |
| RS387906708 |
SMPX
|
Health Risk |
Pathogenic |
Hearing loss, X-linked 4 |
| RS387906709 |
UBQLN2
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 15, Amyotrophic lateral sclerosis type 15 |
| RS387906710 |
UBQLN2
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 15, Amyotrophic lateral sclerosis type 15 |
| RS387906711 |
UBQLN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 15, Amyotrophic lateral sclerosis type 15 |
| RS387906713 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS387906714 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS387906715 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS387906716 |
WAS
|
Health Risk |
Likely pathogenic |
X-linked severe congenital neutropenia, Wiskott-Aldrich syndrome |
| RS387906717 |
WAS
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked severe congenital neutropenia, Wiskott-Aldrich syndrome |
| RS387906718 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS387906719 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS387906720 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS387906721 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS387906722 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS387906724 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS387906725 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-nyhan syndrome, neurologic variant |
| RS387906726 |
PIGA
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS387906727 |
RPL10
|
Health Risk |
risk factor |
Autism, susceptibility to |
| RS387906728 |
UBE2A
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Nascimento type, Syndromic X-linked intellectual disability Nascimento type |
| RS387906729 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Inborn genetic diseases |
| RS387906733 |
MT-TH
|
Health Risk |
Likely pathogenic |
Mitochondrial non-syndromic sensorineural hearing loss, MELAS syndrome |
| RS387906736 |
MT-TW
|
Health Risk |
Likely pathogenic |
Mitochondrial encephalomyopathy, Mitochondrial disease |
| RS387906737 |
DLX5
|
Health Risk |
Pathogenic |
Split hand-foot malformation 1 with sensorineural hearing loss, Split hand-foot malformation 1 with sensorineural hearing loss |
| RS387906738 |
DYNC1H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures |
| RS387906739 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS387906740 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS387906741 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures, Neuronopathy |
| RS387906743 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures, Charcot-Marie-Tooth disease axonal type 2O |
| RS387906744 |
PDE4D
|
Health Risk |
Pathogenic |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS387906745 |
TEK
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple cutaneous and mucosal venous malformations, Vascular skin disorders |
| RS387906746 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS387906747 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS387906748 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS387906749 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS387906750 |
AKR1C2
|
Health Risk |
Pathogenic |
46, XY disorder of sex development due to testicular 17 |
| RS387906751 |
AKR1C2
|
Health Risk |
Pathogenic |
46, XY disorder of sex development due to testicular 17 |
| RS387906752 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS387906753 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS387906754 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS387906755 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS387906756 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS387906758 |
STAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS387906759 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS387906760 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS387906761 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS387906762 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Immunodeficiency 31B |
| RS387906763 |
STAT1
|
Health Risk |
Likely pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Inherited Immunodeficiency Diseases |
| RS387906764 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS387906765 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Immunodeficiency 31B |
| RS387906766 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS387906767 |
STAT1
|
Health Risk |
Likely pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS387906768 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS387906769 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 4, Tetralogy of Fallot |
| RS387906772 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 2, GATA4-related disorder |
| RS387906773 |
NKX2-5
|
Health Risk |
Pathogenic |
Atrial septal defect 7, Atrial septal defect 7 |
| RS387906775 |
NKX2-5
|
Health Risk |
Pathogenic |
Ventricular septal defect 3, Ventricular septal defect 3 |
| RS387906777 |
PDX1
|
Health Risk |
Pathogenic |
Pancreatic agenesis 1, Permanent neonatal diabetes mellitus |
| RS387906778 |
KCNJ5
|
Health Risk |
Pathogenic |
Familial hyperaldosteronism type III, Aldosterone-producing adrenal adenoma |
| RS387906779 |
MTNR1B
|
Health Risk |
risk factor |
Diabetes mellitus type 2, susceptibility to |
| RS387906780 |
SDHA
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Hereditary cancer-predisposing syndrome |
| RS387906781 |
MYLK
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS387906782 |
MYLK
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS387906784 |
IL11RA
|
Health Risk |
Pathogenic |
Craniosynostosis and dental anomalies, Craniosynostosis and dental anomalies |
| RS387906785 |
IL11RA
|
Health Risk |
Likely pathogenic |
Craniosynostosis and dental anomalies, Craniosynostosis and dental anomalies |
| RS387906786 |
IL11RA
|
Health Risk |
Pathogenic |
Craniosynostosis and dental anomalies, Craniosynostosis and dental anomalies |
| RS387906787 |
IL11RA
|
Health Risk |
Pathogenic |
Craniosynostosis and dental anomalies, Craniosynostosis and dental anomalies |
| RS387906788 |
MAP3K1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 6 |
| RS387906789 |
VCP
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS387906790 |
VCP
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS387906791 |
SCARB1
|
Health Risk |
association |
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6, HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6 |
| RS387906792 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N |
| RS387906793 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Cataract 34 multiple types |
| RS387906798 |
KIF1A
|
Health Risk |
Likely pathogenic |
Spastic paraplegia 30B, autosomal recessive |
| RS387906799 |
KIF1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS387906800 |
MAP2K2
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 4, RASopathy |
| RS387906801 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS387906802 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS387906803 |
MUSK
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 9, Congenital myasthenic syndrome 9 |
| RS387906804 |
TUSC3
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 7 |
| RS387906806 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS387906807 |
MYO1E
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 6, Focal segmental glomerulosclerosis 6 |
| RS387906808 |
NCF4
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS387906809 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 4B, Peroxisome biogenesis disorder 4B |
| RS387906810 |
PITX2
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 1, Axenfeld-Rieger syndrome type 1 |
| RS387906812 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 15 |
| RS387906813 |
GATA6
|
Health Risk |
Pathogenic |
Persistent truncus arteriosus, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS387906814 |
GATA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, Atrioventricular septal defect 5 |
| RS387906816 |
GATA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 9, Tetralogy of Fallot |
| RS387906817 |
GATA6
|
Health Risk |
Pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS387906818 |
GATA6
|
Health Risk |
Pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Abnormal cardiovascular system morphology |
| RS387906819 |
GATA6
|
Health Risk |
Pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS387906821 |
OSMR
|
Health Risk |
Pathogenic |
Amyloidosis, primary localized cutaneous |
| RS387906822 |
OSMR
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyloidosis, primary localized cutaneous |